Internal Medicine — Old Senior Academic Day Lectures (Until Sep 2023)
Medications and therapies of common dermatological disorders
EPAs mapped to this activity
None.
Competencies covered in this activity
| 1. Practise medicine within their defined scope of practice and expertise | ||||||
| 1.3. Apply knowledge of the clinical and biomedical sciences relevant to Internal Medicine | ||||||
| 1.3.8. Pharmacology as it relates to pharmacokinetics, pharmacodynamics, mechanism of action, routes of delivery and elimination, and adverse effects of medications | ||||||
| 1.3.8.1. Analgesics | ||||||
| 1.3.8.2. Antimicrobials | ||||||
| 1.3.8.3. Cardiovascular medications | ||||||
| 1.3.8.4. Endocrine medications | ||||||
| 1.3.8.5. Immune modulating therapies | ||||||
| 1.3.8.6. Neuropsychiatric medications | ||||||
| 1.3.8.7. Respiratory medications | ||||||
| 1.3.8.8. Systemic therapies for cancer | ||||||
| 1.3.8.9. Drugs commonly used recreationally | ||||||
| 1.3.8.10. Supplementary and complementary medications | ||||||
| 1.4. Apply knowledge of the following systems, clinical scenarios, conditions, diseases and therapies applicable to Internal Medicine, including the manifestations, investigation, and management | ||||||
| 1.4.11. Dermatologic | ||||||
| 1.4.11.1. Symptoms | ||||||
| 1.4.11.1.1. Pruritus | ||||||
| 1.4.11.2. Findings and investigations | ||||||
| 1.4.11.2.1. Abnormalities of nails | ||||||
| 1.4.11.2.2. Clubbing | ||||||
| 1.4.11.2.3. Maculopapular eruptions | ||||||
| 1.4.11.2.4. Petechiae, purpura, ecchymosis | ||||||
| 1.4.11.2.5. Pigmented lesions | ||||||
| 1.4.11.2.6. Urticaria | ||||||
| 1.4.11.2.7. Vesicular eruptions | ||||||
| 1.4.11.2.8. Skin and nail manifestations due to systemic disease | ||||||
| 1.4.11.2.8.1. Celiac disease | ||||||
| 1.4.11.2.8.2. Connective tissue disease | ||||||
| 1.4.11.2.8.3. Endocrine and metabolic disease | ||||||
| 1.4.11.2.8.4. Inflammatory bowel disease | ||||||
| 1.4.11.2.8.5. Malignancy | ||||||
| 1.4.11.2.8.6. Nutritional deficiencies | ||||||
| 1.4.11.2.8.7. Systemic immunosuppression | ||||||
| 1.4.11.3. Conditions | ||||||
| 1.4.11.3.1. Bullous skin disease | ||||||
| 1.4.11.3.2. Eczema | ||||||
| 1.4.11.3.3. Erythema nodosum | ||||||
| 1.4.11.3.4. Psoriasis | ||||||
| 1.4.11.3.5. Stasis dermatitis | ||||||
| 1.4.11.3.6. Stevens-Johnson syndrome | ||||||
| 1.4.11.3.7. Toxic epidermal necrolysis | ||||||
| 1.4.11.3.8. Skin cancer and pre-malignant conditions | ||||||
Training experiences included in this activity
None.